Mirabilis closes $10.5m in series A extension:
This article was originally published in Clinica
Seattle, Washington-based Mirabilis Medica has received $10.5m in funding after it closed an extension to a series A financing round that initially took place last year. The financing, which adds to the $4m raised during the original round (see Clinica's Medtech Ventures No 1, p 2), was led by Arboretum Ventures. It also included investments from Split Rock Partners, Dow Venture Capital and an individual investor. Mirabilis is seeking funds to back the continued development and testing of its image-guided, high-intensity focused ultrasound (HIFU) system for treating gynaecological diseases.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.